These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32526622)

  • 1. Development of a targeted nanoLC-MS/MS method for quantitation of residual toxins from Bordetella pertussis.
    Szymkowicz L; Wilson DJ; James DA
    J Pharm Biomed Anal; 2020 Sep; 188():113395. PubMed ID: 32526622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in
    Szymkowicz L; Gerard J; Messham B; Tam WWV; James DA
    Toxins (Basel); 2021 Oct; 13(11):. PubMed ID: 34822547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Teruya S; Hiramatsu Y; Nakamura K; Fukui-Miyazaki A; Tsukamoto K; Shinoda N; Motooka D; Nakamura S; Ishigaki K; Shinzawa N; Nishida T; Sugihara F; Maeda Y; Horiguchi Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.
    DiVenere AM; Amengor D; Silva RP; Goldsmith JA; McLellan JS; Maynard JA
    mBio; 2022 Aug; 13(4):e0152722. PubMed ID: 35920558
    [No Abstract]   [Full Text] [Related]  

  • 6. Pasteurian Contributions to the Study of
    Locht C
    Toxins (Basel); 2023 Feb; 15(3):. PubMed ID: 36977067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineering of
    Ladant D
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
    Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
    Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.
    Scanlon K; Skerry C; Carbonetti N
    Adv Exp Med Biol; 2019; 1183():35-51. PubMed ID: 31376138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.
    Cherry JD; Xing DX; Newland P; Patel K; Heininger U; Corbel MJ
    Clin Infect Dis; 2004 Feb; 38(4):502-7. PubMed ID: 14765342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis.
    Eby JC; Gray MC; Warfel JM; Merkel TJ; Hewlett EL
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27760780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics of Bordetella pertussis toxins.
    Antoine R; Raze D; Locht C
    Int J Med Microbiol; 2000 Oct; 290(4-5):301-5. PubMed ID: 11111902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for a new acellular pertussis vaccine.
    Manclark CR; Burns DL
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):323-9. PubMed ID: 2870676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella Adenylate Cyclase-Hemolysin Toxins.
    Guiso N
    Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28892012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.
    Carbonetti NH
    Future Microbiol; 2010 Mar; 5(3):455-69. PubMed ID: 20210554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
    Weiss AA; Hewlett EL; Myers GA; Falkow S
    J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins.
    Khelef N; Bachelet CM; Vargaftig BB; Guiso N
    Infect Immun; 1994 Jul; 62(7):2893-900. PubMed ID: 7999145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Post-Translational Modifications and Cytotoxic Properties of the Adenylate-Cyclase Hemolysin Produced by Various Bordetella pertussis and Bordetella parapertussis Isolates.
    Bouchez V; Douché T; Dazas M; Delaplane S; Matondo M; Chamot-Rooke J; Guiso N
    Toxins (Basel); 2017 Sep; 9(10):. PubMed ID: 28954396
    [No Abstract]   [Full Text] [Related]  

  • 20. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.
    Kerr JR; Matthews RC
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):77-88. PubMed ID: 10746492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.